Overactive Bladder - Results from #1720

Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women - Abstract December 19, 2012

Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults - Abstract December 18, 2012

Mirabegron: A review of recent data and its prospects in the management of overactive bladder - Abstract December 17, 2012

β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men - Abstract December 14, 2012

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine - Abstract December 14, 2012

Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects - Abstract December 13, 2012

Validation of the Patient Global Impression scales for use in detrusor overactivity: Secondary analysis of the RELAX study - Abstract December 13, 2012

Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron - Abstract December 13, 2012

Urological problems in Parkinson's disease: Clinical aspects - Abstract December 13, 2012

Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study - Abstract December 11, 2012

Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action - Abstract December 11, 2012

Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome - Abstract December 11, 2012

Urge perception index: A quantitative measure of bladder hyper-sensitivity in analysis of a bladder diary with a self-reported grading of urinary perception - Abstract December 10, 2012

Increased risk of large postvoid residual urine and lower long-term success rate in frail elderly after intravesical onabotulinumtoxin A injection for refractory idiopathic detrusor overactivity - Abstract December 10, 2012

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial - Abstract December 7, 2012

Five years follow-up study and failures analysis of botulinum toxin repeated injections to treat neurogenic detrusor overactivity - Abstract December 6, 2012

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder - Abstract December 6, 2012

Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder - Abstract December 6, 2012

Clinical findings associated with bladder trabeculations in women - Abstract December 4, 2012

Urinary neurotrophic factors in healthy individuals and patients with overactive bladder - Abstract December 4, 2012

Page 87 of 106

SUFU MyBladder app

email news signup